Skip to content
Eversight_Academy_Logo_Horz

Webinars

Eversight Academy’s free webinars are a great way for you to connect, learn and train digitally with leading ophthalmologists and researchers from around the world.

We invite you to register for any of our upcoming webinars and watch past webinar sessions.

Have an idea for a future topic? Interested in receiving timely and relevant information from Eversight? We'd love to hear from you!

Scheduled


A complete approach to limbal stem cell deficiency: KLAL-Pro & postoperative management strategies

Presenters: Nambi Nallasamy, MD & Edward J. Holland, MD

Date: 7 p.m. ET Monday, Nov. 10

This unique webinar will discuss management of the most challenging cases of limbal stem cell deficiency (LSCD) from two leading experts, including the latest developments in eye bank processed tissue for keratolimbal allograft (KLA) surgery: KLAL-Pro.

Nambi Nallasamy, MD, is a board-certified ophthalmologist, fellowship-trained cornea specialist and Assistant Professor of Ophthalmology & Visual Sciences at the University of Michigan Kellogg Eye Center. He specializes in the medical surgical management of corneal and ocular surface disease, including corneal transplantation (e.g., DSEK, DMEK, DALK, and PKP), cataract and refractive surgery, secondary intraocular lens implantation and lens exchange, corneal infections, dystrophies, tumors and limbal stem cell deficiency (LSCD)—including amniotic membrane grafts, keratoprostheses and limbal stem cell transplantation.

Edward J. Holland, MD, is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He attended the Loyola-Stritch School of Medicine in Chicago and trained in ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa and a second in ocular immunology at the National Eye Institute, National Institutes of Health in Bethesda, Maryland. Dr. Holland's clinical interests include corneal transplantation, ocular surface transplantation, ocular trauma and cataract surgery. He has published extensively, authoring 250+ articles in peer reviewed journals and was the co-principal investigator of the Cornea Donor Study; the largest clinical trial ever conducted in the field of cornea. Dr. Holland has attracted worldwide referrals for medical and surgical corneal problems and for stem cell transplantation. He and his team at CEI/University of Cincinnati have the largest ocular surface transplant program in the world.


Recordings


Management of limbal stem cell deficiency | Webinar recap

Management of limbal stem cell deficiency | Webinar recap

Disclaimer: Medical information is not medical advice—read our disclaimer. Limbal stem cell deficiency (LSCD) presents a complex clinical ch

Endothelium-in DMEK in complex eyes | Webinar recap

Endothelium-in DMEK in complex eyes | Webinar recap

Disclaimer: Medical information is not medical advice—read our disclaimer. The February 2025 Eversight Academy webinar set the stage for an

Antibody-drug conjugates and the ocular surface | Webinar recap

Antibody-drug conjugates and the ocular surface | Webinar recap

By Caithlin Lopes, Senior Director, Business Development Disclaimer: Medical information is not medical advice—read our disclaimer. The Dece

Applications of AI in the Management of Cornea Disease | Webinar recap

Applications of AI in the Management of Cornea Disease | Webinar recap

Disclaimer: Medical information is not medical advice—read our disclaimer. The September 2024 Eversight Academy webinar featured Travis Redd

Succession planning & physician recruitment: It's never too early

Succession planning & physician recruitment: It's never too early

Disclaimer: Medical information is not medical advice—read our disclaimer. The November 2024 Eversight Academy webinar featured Jill Maher,

Why office-based surgery? | Eversight webinar recap

Why office-based surgery? | Eversight webinar recap

Disclaimer: Medical information is not medical advice—read our disclaimer. The July 2024 Eversight Academy webinar featured Parag Majmudar,

Understanding ocular graft-versus-host disease | Eversight webinar recap

Understanding ocular graft-versus-host disease | Eversight webinar recap

Disclaimer: Medical information is not medical advice—read our disclaimer. What is ocular graft-vs-host disease (GVHD)? GVHD occurs in peopl

Developing a sustainable, impactful international keratoplasty skills transfer program | Eversight webinar recap

Developing a sustainable, impactful international keratoplasty skills transfer program | Eversight webinar recap

We were joined by Dr. Anthony Aldave for Eversight’s first webinar of 2024 titled, “Developing a sustainable, impactful international kerato

A journey in amniotic membrane transplantation for Stevens-Johnson syndrome | Eversight webinar recap

A journey in amniotic membrane transplantation for Stevens-Johnson syndrome | Eversight webinar recap

Hajirah Saeed, MD begins the webinar by showing a striking image of a patient with corneal blindness with complete xerosis secondary to Stev

Improving access to donation and transplantation services through global cooperation and harmonization | Eversight webinar recap

Improving access to donation and transplantation services through global cooperation and harmonization | Eversight webinar recap

Heather Machin, RN, MBA, PhD, begins the webinar with her case for cooperation and harmonization among the world’s eye banks as an avenue to

Amniotic membrane: The magic bullet | Eversight webinar recap

Amniotic membrane: The magic bullet | Eversight webinar recap

Background & history Natalie Cheung, MD, begins the webinar with a brief discussion of the history of using human amniotic membrane (AM)

Innovative dry eye therapies | Eversight webinar recap

Innovative dry eye therapies | Eversight webinar recap

Dry eye is a common condition affecting millions of people globally. While standard treatments for dry eye exist, what can be done when stan

Novel advances in the cornea and eye banking field | Eversight webinar recap

Novel advances in the cornea and eye banking field | Eversight webinar recap

We were joined by three recent Eye & Vision Research Grant recipients to update us on their research work in the field of ophthalmology.

Cornea and vitamin A: a new perspective | Eversight webinar recap

Cornea and vitamin A: a new perspective | Eversight webinar recap

We were joined by Mohammad H. Dastjerdi, MD, of Rutgers New Jersey Medical School for our January webinar "Cornea and vitamin A: a new persp

Manual DALK techniques for keratoconus | Eversight webinar recap

Manual DALK techniques for keratoconus | Eversight webinar recap

We were joined by Dr. Uri Soiberman of the Johns Hopkins Wilmer Eye Institute for our November 2022 webinar. Dr. Soiberman offered his exper

DSAEK surgery in the glaucoma patient | Eversight webinar recap

DSAEK surgery in the glaucoma patient | Eversight webinar recap

Oct. 25, 2022 — We were joined by Dr. Daniel Montenegro of the Eye Centers of South Florida for our October 2022 webinar. Dr. Montenegro led

Current Practice Patterns for IOL Calculations in Patients with Corneal Disease | Eversight webinar recap

Current Practice Patterns for IOL Calculations in Patients with Corneal Disease | Eversight webinar recap

Oct. 6, 2022 — We were joined by Dr. Kamran Riaz, MD of Dean McGee Eye Institute at the University of Oklahoma in Oklahoma City for our Sept

Eversight Webinar graphic

Artificial iris or artificial cornea: A tale of two protheses | Eversight webinar recap

We were joined by Ahmed Omar, MD, PhD, of University Hospital Eye Institute at Case Western Reserve University for our July 2022 webinar. Dr

Cataract surgery in Fuchs' dystrophy | Eversight webinar recap

Cataract surgery in Fuchs' dystrophy | Eversight webinar recap

July 8, 2022 — We were joined by Divya Srikumaran, MD, of Johns Hopkins Wilmer Eye Institute for our June 2022 webinar. She discussed her al